Ethics declarations Ethical Approval This article does not contain any studies with human or animal subjects performed by any of the authors
Oral BPC-157 (in capsule form) has been used at 500 mcg to 1,000 mcg daily for gut-specific indications, though oral bioavailability data in humans is not established
Common minor side effects include temporary injection site reactions (redness, mild swelling, discomfort), occasional mild gastrointestinal effects, temporary headaches during initial treatment, and potential mild detoxification symptoms as cellular toxin mobilization increases
Ask the physician to submit a prescription and necessary prior authorization to the central processor, Humana, and not the Part D plan
Frequently Asked Questions What is the best overall syringe for BPC-157